Miyako Taniguchi

1.2k total citations
23 papers, 886 citations indexed

About

Miyako Taniguchi is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Miyako Taniguchi has authored 23 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 8 papers in Molecular Biology and 6 papers in Psychiatry and Mental health. Recurrent topics in Miyako Taniguchi's work include Alzheimer's disease research and treatments (9 papers), Lysosomal Storage Disorders Research (9 papers) and Dementia and Cognitive Impairment Research (6 papers). Miyako Taniguchi is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Lysosomal Storage Disorders Research (9 papers) and Dementia and Cognitive Impairment Research (6 papers). Miyako Taniguchi collaborates with scholars based in Japan, United States and France. Miyako Taniguchi's co-authors include Katsuya Urakami, Daiki Jimbo, Masashi Inoue, Yuki Kimura, Kousaku Ohno, Katsumi Higaki, Haruaki Ninomiya, Shinjiro Akaboshi, Yoko Shinoda and Eiji Nanba and has published in prestigious journals such as Journal of Biological Chemistry, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease and European Journal of Clinical Nutrition.

In The Last Decade

Miyako Taniguchi

23 papers receiving 864 citations

Peers

Countries citing papers authored by Miyako Taniguchi

Since Specialization

Citations

This map shows the geographic impact of Miyako Taniguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyako Taniguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyako Taniguchi more than expected).

Fields of papers citing papers by Miyako Taniguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miyako Taniguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyako Taniguchi. The network helps show where Miyako Taniguchi may publish in the future.

Co-authorship network of co-authors of Miyako Taniguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Miyako Taniguchi. A scholar is included among the top collaborators of Miyako Taniguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miyako Taniguchi. Miyako Taniguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of monosodium l-glutamate (umami substance) on cognitive function in people with dementia 2018 ·European Journal of Clinical Nutrition ·(unknown), Miyako Taniguchi, Tetsuya Suzuki, (unknown), (unknown), (unknown), Hideki Matsumoto, Katsuya Urakami	21
2	The relationship between the diagnosis method of neuronal dysfunction (DIMENSION) and brain pathology in the early stages of Alzheimer's disease 2013 ·Psychogeriatrics ·(unknown), (unknown), Miyako Taniguchi, Toshimitsu Musha, Katsuya Urakami	8
3	Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer’s disease subjects 2012 ·Molecular Neurodegeneration ·Saori Hata, Miyako Taniguchi, (unknown), Takeshi Ikeuchi, Anne M. Fagan, David M. Holtzman, Randall J. Bateman, Hamid R. Sohrabi, Ralph N. Martins, Sam Gandy, Katsuya Urakami, Toshiharu Suzuki, (unknown)	12
4	P1‐036: Altered glycosylation in serum proteins of Alzheimer's disease 2012 ·Alzheimer s & Dementia ·Miyako Taniguchi, Katsuya Urakami	1
5	Specific feature of olfactory dysfunction with Alzheimer's disease inspected by the Odor Stick Identification Test 2011 ·Psychogeriatrics ·Daiki Jimbo, Masashi Inoue, Miyako Taniguchi, Katsuya Urakami	22
6	Touch Panel‐type Dementia Assessment Scale: a new computer‐based rating scale for Alzheimer's disease 2011 ·Psychogeriatrics ·Masashi Inoue, Daiki Jimbo, Miyako Taniguchi, Katsuya Urakami	46
7	Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of asymptomatic giant cell arteritis in a patient with Alzheimer's disease 2010 ·Geriatrics and gerontology international ·(unknown), (unknown), Hisafumi Yasuda, Hiroaki Moriyama, (unknown), (unknown), Miyako Taniguchi, Katsuya Urakami, Koichi Yokono, Takashi Sakurai	1
8	Effect of aromatherapy on patients with Alzheimer's disease 2009 ·Psychogeriatrics ·Daiki Jimbo, Yuki Kimura, Miyako Taniguchi, Masashi Inoue, Katsuya Urakami	164
9	Alcadein Cleavages by Amyloid β-Precursor Protein (APP) α- and γ-Secretases Generate Small Peptides, p3-Alcs, Indicating Alzheimer Disease-related γ-Secretase Dysfunction 2009 ·Journal of Biological Chemistry ·Saori Hata, (unknown), Yoichi Araki, Naoko Kato, (unknown), Masaki Nishimura, Dieter Hartmann, Paul Säftig, Falk Fahrenholz, Miyako Taniguchi, Katsuya Urakami, Hiroyasu Akatsu, Ralph N. Martins, Kazuo Yamamoto, Masahiro Maeda, Tohru Yamamoto, Tadashi Nakaya, Sam Gandy, Toshiharu Suzuki	40
10	Sugar Chains of Cerebrospinal Fluid Transferrin as a New Biological Marker of Alzheimer’s Disease 2008 ·Dementia and Geriatric Cognitive Disorders ·Miyako Taniguchi, (unknown), Yuki Hashimoto, (unknown), Daiki Jimbo, Yosuke Wakutani, Kenji Wada‐Isoe, Kenji Nakashima, Hiroyasu Akatsu, Katsutoshi Furukawa, Hiroyuki Arai, Katsuya Urakami	33
11	Early detection and biomarker for dementia 2007 ·Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics ·Katsuya Urakami, Miyako Taniguchi	1
12	N-Octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease 2004 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), Yuko Sugimoto, Yuki Ohsaki, Haruaki Ninomiya, Akira Oka, Miyako Taniguchi, Hiroyuki Ida, Yoshikatsu Eto, Seiichiro Ogawa, Yumi Matsuzaki, (unknown), Takehiko Inoue, Katsumi Higaki, Eiji Nanba, Kousaku Ohno, Yoshiyuki Suzuki	109
13	Increased NPC1 mRNA in skin fibroblasts from Niemann-Pick disease type C patients 2003 ·Brain and Development ·Toshiyuki Yamamoto, Jianhua Feng, Katsumi Higaki, Miyako Taniguchi, Eiji Nanba, Haruaki Ninomiya, Kousaku Ohno	8
14	Progressive neuronal loss in the ventral posterior lateral and medial nuclei of thalamus in Niemann–Pick disease type C mouse brain 2001 ·Brain and Development ·Atsuko Yamada, Makoto Saji, (unknown), Yoko Shinoda, Miyako Taniguchi, Katsumi Higaki, Haruaki Ninomiya, Kousaku Ohno	45
15	Sites and temporal changes of gangliosides GM1/GM2 storage in the Niemann–Pick disease type C mouse brain 2001 ·Brain and Development ·Miyako Taniguchi, Yoko Shinoda, Haruaki Ninomiya, Marie T. Vanier, (unknown)	36
16	NPC1 gene mutations in Japanese patients with Niemann-Pick disease type C 1999 ·Human Genetics ·(unknown), Eiji Nanba, Haruaki Ninomiya, Katsumi Higaki, Miyako Taniguchi, Haidi Zhang, Shinjiro Akaboshi, (unknown), Takao Takeshima, Koji Inui, (unknown), Akemi Tanaka, Norio Sakuragawa, Gilles Millat, Marie T. Vanier, Jill A. Morris, Peter G. Pentchev, (unknown)	70
17	Increased levels of GM2 ganglioside in fibroblasts from a patient with juvenile Niemann–Pick disease type C 1998 ·Brain and Development ·Yasuhiro Watanabe, Shinjiro Akaboshi, Gen Ishida, Takao Takeshima, Tamami Yano, Miyako Taniguchi, Kousaku Ohno, Kenji Nakashima	29
18	Decreased membrane fluidity and unsaturated fatty acids in Niemann–Pick disease type C fibroblasts 1998 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Tomohiro Koike, Gen Ishida, Miyako Taniguchi, Katsumi Higaki, (unknown), Makiko Saito, Yoichi Sakakihara, Masao Iwamori, Kousaku Ohno	57
19	Accumulation of cholesterol and GM2 ganglioside in cells cultured in the presence of progesterone: an implication for the basic defect in Niemann-Pick disease type C 1998 ·Brain and Development ·Masahiro Sato, Shinjiro Akaboshi, Tetsuo Katsumoto, Miyako Taniguchi, Katsumi Higaki, Tadashi Tai, Hitoshi Sakuraba, Kousaku Ohno	22
20	Accumulation of GM2 Ganglioside in Niemann-Pick Disease Type C Fibroblasts. 1996 ·Proceedings of the Japan Academy Series B ·Tamami Yano, Miyako Taniguchi, Shinjiro Akaboshi, Marie‐Thérèse Vanier, Tadashi Tai, Hitoshi Sakuraba, Kousaku Ohno	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact